☆ 4.4 Letter

Intrabronchial Administration of Activated Recombinant Factor VII in a Young Child With Diffuse Alveolar Hemorrhage

PEDIATRIC BLOOD & CANCER (2014)

Journal

PEDIATRIC BLOOD & CANCER

Volume 61, Issue 3, Pages 570-571

Publisher

WILEY-BLACKWELL

DOI: 10.1002/pbc.24841

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Diffuse alveolar hemorrhage in a healthy stem cell donor following administration of granulocyte colony-stimulating factor

Yotam Kolben, Fares Darawshy, Barhoum Barhoum, Avraham Abutbul, Rottem Kuint

Summary: G-CSF, commonly used in healthy adults prior to stem cell donation, can lead to rare but life-threatening pulmonary adverse events such as diffuse alveolar hemorrhage. Healthcare providers should be aware of this potential complication.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy

Daniel Laxar, Eva Schaden, Marion Wiegele, Konrad Hoetzenecker, Stefan Schwarz, Johannes Gratz

Summary: This study investigates the effect of rFVIIa on bleeding in lung transplant patients undergoing ECMO therapy. Results show that only 14% of rFVIIa administrations were effective in controlling bleeding, while 71% of patients required surgery for bleeding control. Although 84% of recommended preconditions were fulfilled, their fulfillment was not associated with rFVIIa efficacy. The incidence of thromboembolic events after rFVIIa administration was comparable to patients not receiving rFVIIa.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Critical Care Medicine

Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation

Zhenmei Zhang, Can Wang, Steve G. Peters, William J. Hogan, Shahrukh K. Hashmi, Mark R. Litzow, Mrinal S. Patnaik, Alexander S. Niven, Hemang Yadav

Summary: DAH after HCT has a low incidence rate but high mortality rate, requiring attention. Multiple factors may influence the incidence rate, mortality rate, and risk factors, including time of onset, platelet count, and the need for invasive mechanical ventilation. For treatment outcomes, lower doses of steroids may help improve patient survival.

CHEST (2021)

Add to Collection

Review Anesthesiology

Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

Brigid C. Flynn, Marie E. Steiner, Michael Mazzeffi

Summary: This review examines the historical and current off-label use of recombinant activated factor VII for cardiac surgical bleeding.

ANESTHESIOLOGY (2023)

Add to Collection

Article Immunology

Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis

Zhongnan Yang, Lei Yan, Huixia Cao, Yue Gu, Pan Zhou, Mingyue Shi, Guodong Li, Xiaojing Jiao, Na Li, Xiangnan Li, Kai Sun, Fengmin Shao

Summary: The study showed that erythropoietin (EPO) can alleviate diffuse alveolar hemorrhage (DAH) by reducing macrophage recruitment and promoting phenotype switch, suggesting its potential as a therapeutic agent for DAH. Further research is needed to validate the direct target of miR-494-3p in regulating JAK2/STAT3 signaling transduction.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Hematology

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia

Man-Chiu Poon

Summary: The study summarized evidence from three different sources demonstrating the efficacy and safety of rFVIIa in patients with GT without refractoriness or antibodies to platelets, supporting the label extension of rFVIIa as an alternative treatment when platelets are unavailable.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Review Respiratory System

Diffuse Alveolar Hemorrhage in Cardiac Diseases

Biplab K. Saha, Woon H. Chong

Summary: Diffuse alveolar hemorrhage is a rare condition with diverse etiologies, where cardiac diseases are often underestimated causes, particularly heart failure and mitral valve diseases being the most common. DAH is typically caused by the stress failure of pulmonary capillaries due to pulmonary venous hypertension, with a contribution from the bronchial circulation.

LUNG (2021)

Add to Collection

Article Immunology

Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus

Haoyang Zhuang, Shuhong Han, Li Lu, Westley H. Reeves

Summary: Serp-1 can prevent pristane-induced lung hemorrhage by enhancing LXR-regulated M2 macrophage polarization and KLH4-regulated IL-10 production, offering a potential new therapy for this severe complication of SLE.

CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Steroid myopathy in a child with diffuse alveolar hemorrhage: a case report

Yongshuang Fang, Lang Yuan, Ran Zhao, Kun Jiang, Xiaoyan Dong

Summary: Steroid myopathy is a side effect of glucocorticoid treatment, which can occur even in pediatric patients as shown in this case study. It is important to consider the possibility of steroid myopathy when patients with respiratory diseases experience decreased muscle strength following glucocorticoid therapy.

ANNALS OF PALLIATIVE MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Case Report: Delayed Diffuse Alveolar Hemorrhage in Echis sochureki Envenoming, Jodhpur, India

Akhilesh Kumar, Maya Gopalakrishnan, Harshavardhan R. Kuri, Archana Bajpayee, Nikhil Kothari, Mahendra Kumar Garg

Summary: This case report highlights an uncommon presentation of delayed pulmonary hemorrhage after snakebite envenoming. The patient showed initial venom-induced consumption coagulopathy followed by diffuse alveolar hemorrhage (DAH), which was successfully treated with immunosuppressants and plasma exchange. Although persistent hypofibrinogenemia was observed, the patient remained healthy during the follow-up period.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2022)

Add to Collection

Article Pediatrics

Diffuse alveolar hemorrhage in a pediatric patient with systemic lupus erythematosus

Lucas Hamrick, Seth J. Deskins, Saif Al-Qatarneh

Summary: A 15-year-old female patient presented with symptomatic anemia, fatigue, dyspnea, and weight loss, which were later diagnosed as systemic lupus erythematosus. She developed respiratory failure and bilateral pleural effusions during her hospital admission, but her symptoms improved with treatment.

PEDIATRIC PULMONOLOGY (2023)

Add to Collection

Article Emergency Medicine

Early initiation of extracorporeal membrane oxygenation (ECMO) in emergency department to rescue severe diffuse alveolar hemorrhage

Lei Zhang, Lina Liu, Caiwei Lin, Xudong Wang

Summary: Diffuse alveolar hemorrhage (DAH) is a serious disease with main symptoms of hemoptysis and dyspnea, and ECMO can provide oxygenation support when mechanical ventilation fails. Early initiation of V-V ECMO can rescue patients' lives.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia

Amir M. Ansari, Adam Khorasanchi, Armaghan Faghihimehr, Amir Toor

Summary: Hemorrhage in patients with hematologic malignancies is challenging to manage due to coagulopathy and thrombocytopenia. Recombinant FVIIa has been used as a last resort in various clinical settings to control bleeding, with variable outcomes. This case report presents the use of recombinant FVIIa in a patient with multiple myeloma and profound transfusion refractory thrombocytopenia suffering from traumatic subdural hematoma.

CLINICAL CASE REPORTS (2021)

Add to Collection

Article Respiratory System

Successful hemostasis in refractory alveolar hemorrhage using low- dose recombinant activated factor VII

John Selickman, Jacob Fiocchi, Hem Desai, Kathryn M. Pendleton

Summary: Diffuse alveolar hemorrhage (DAH) is a life-threatening condition that can be difficult to control, especially in severe cases. This case report describes a patient with DAH caused by granulomatosis with polyangiitis, who showed improvement in hemostasis and oxygenation after receiving a lower dose of rFVIIa.

RESPIRATORY MEDICINE CASE REPORTS (2022)

Add to Collection

Review Anesthesiology

Efficacy, Safety, and Strategies for Recombinant-Activated Factor VII in Cardiac Surgical Bleeding: A Narrative Review

Brent Kidd, Lauren Sutherland, Craig S. Jabaley, Brigid Flynn

Summary: Perioperative bleeding remains a significant factor affecting morbidity and mortality in cardiac surgery, and the search for an ideal hemostatic agent continues. The use of blood products is associated with increased costs and risks, including infection, prolonged mechanical ventilation, extended length of stay, and decreased survival. Recombinant-activated factor VII (rFVIIa) has been approved for use in various clinical settings since 1999. This review provides a summary of the existing literature, society recommendations, and current guidelines regarding the perioperative use of rFVIIa in cardiac surgery.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)

Add to Collection

Review Pediatrics

Neonatal sepsis definitions from randomised clinical trials

Rian Hayes, Jack Hartnett, Gergana Semova, Cian Murray, Katherine Murphy, Leah Carroll, Helena Plapp, Louise Hession, Jonathan O'Toole, Danielle McCollum, Edna Roche, Elinor Jenkins, David Mockler, Tim Hurley, Matthew McGovern, John Allen, Judith Meehan, Frans B. Plotz, Tobias Strunk, Willem P. de Boode, Richard Polin, James L. Wynn, Marina Degtyareva, Helmut Kuester, Jan Janota, Eric Giannoni, Luregn J. Schlapbach, Fleur M. Keij, Irwin K. M. Reiss, Joseph Bliss, Joyce M. Koenig, Mark A. Turner, Christopher Gale, Eleanor J. Molloy

Summary: Neonatal sepsis, a leading cause of infant mortality, has diverse definitions based on microbiological culture, laboratory tests, and clinical signs. An international consensus-based definition could improve research comparability and clinical outcomes.

PEDIATRIC RESEARCH (2023)

Add to Collection

Article Pediatrics

Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference

E. Vincent S. Faustino, Oliver Karam, Robert Parker, Sheila J. Hanson, Leonardo R. Brandao, Paul Monagle

Summary: This study reviewed current evidence and proposed criteria for diagnosing coagulation dysfunction in critically ill children. The study identified several potential indicators of coagulation dysfunction and emphasized the need for future validation.

PEDIATRICS (2022)

Add to Collection

Article Immunology

Novel Human Parechovirus 3 Diversity, Recombination, and Clinical Impact Across 7 Years: An Australian Story

Seweryn Bialasiewicz, Meryta May, Sarah Tozer, Rebecca Day, Anne Bernard, Julian Zaugg, Kyana Gartrell, Soren Alexandersen, Anthony Chamings, Claire Y. T. Wang, Julia Clark, Keith Grimwood, Claire Heney, Luregn Schlapbach, Robert S. Ware, David Speers, Ross M. Andrews, Stephen Lambert

Summary: A study found that the recombinant strain of human parechovirus 3 (HPeV3-AR) was the dominant strain in the outbreaks of sepsis-like illnesses in infants in Australia. However, this strain was not associated with increased disease severity.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

Review Critical Care Medicine

Reporting of Social Determinants of Health in Pediatric Sepsis Studies*

Kusum R. Menon, Lauren Sorce, Andrew D. Argent, Tellen D. Bennett, Enitan Carrol, Niranjan Kissoon, L. Nelson J. Sanchez-Pinto, Luregn C. Schlapbach, Daniela de Souza, R. Scott L. Watson, James J. Wynn, Jerry Zimmerman, Suchitra Ranjit

Summary: There is low reporting frequency and significant variability in categorization and definition of social determinants of health (SDOH) variables in studies on pediatric sepsis. Consistent and standardized reporting of SDOH is needed to understand the association of SDOH with illness severity and outcomes, compare populations and extrapolate study results, and identify potentially modifiable socioeconomic factors for policy makers.

PEDIATRIC CRITICAL CARE MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Validation of a paediatric sepsis screening tool to identify children with sepsis in the emergency department: a statewide prospective cohort study in Queensland, Australia

Patricia Gilholm, Kristen Gibbons, Paula Lister, Amanda Harley, Adam Irwin, Sainath Raman, Michael Rice, Luregn J. Schlapbach

Summary: The study aimed to validate and derive a simplified paediatric sepsis screening tool. The screening tool showed good predictive performance, and a simplified version with 16 criteria achieved comparable results. Implementing sepsis screening tools may improve the timely recognition and treatment of sepsis.

BMJ OPEN (2023)

Add to Collection

Article Pediatrics

Effect of Saline vs Gluconate/Acetate-Buffered Solution vs Lactate-Buffered Solution on Serum Chloride Among Children in the Pediatric Intensive Care Unit The SPLYT-P Randomized Clinical Trial

Sainath Raman, Kristen S. S. Gibbons, Adrian Mattke, Andreas Schibler, Peter Trnka, Melanie Kennedy, Renate Le Marsney, Luregn J. J. Schlapbach

Summary: This study aimed to compare the effects of balanced solutions and saline on the rise of plasma chloride in critically ill children. The results showed that the use of balanced solutions reduced the incidence of rise in plasma chloride compared with saline, and had less impact on renal function.

JAMA PEDIATRICS (2023)

Add to Collection

Editorial Material Pediatrics

Pragmatic trials for critical illness in neonates and children

Luregn J. Schlapbach, Mark J. Peters

LANCET CHILD & ADOLESCENT HEALTH (2023)

Add to Collection

Article Pediatrics

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial

Tatjana Welzel, Andrew Atkinson, Nina Schobi, Maya C. Andre, Douggl G. N. Bailey, Geraldine Blanchard-Rohner, Michael Buettcher, Serge Grazioli, Henrik Koehler, Marie-Helene Perez, Johannes Truck, Federica Vanoni, Petra Zimmermann, Carlos Sanchez, Julia A. Bielicki, Luregn J. Schlapbach

Summary: This study aimed to evaluate the effectiveness of intravenous methylprednisolone compared with intravenous immunoglobulins in children with PIMS-TS. The results showed no significant difference in the length of hospital stay between the methylprednisolone group and the immunoglobulin group, but fewer patients in the methylprednisolone group required respiratory support.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Add to Collection

Article Health Care Sciences & Services

Nitric Oxide on Extracorporeal Membrane Oxygenation in Neonates and Children (NECTAR Trial): Protocol for a Randomized Controlled Trial

Adrian C. Mattke, Kerry Johnson, Kristen Gibbons, Debbie Long, Jeremy Robertson, Prem S. Venugopal, Antje Blumenthal, Andreas Schibler, Luregn Schlapbach

Summary: This article describes a study on the feasibility and safety of mixing nitric oxide (NO) into extracorporeal membrane oxygenation (ECMO) systems. The study aims to assess the impact of NO on inflammation and coagulation system activation during ECMO support. The goal is to improve outcomes for children receiving ECMO treatment.

JMIR RESEARCH PROTOCOLS (2023)

Add to Collection

Article Critical Care Medicine

Machine learning to predict poor school performance in paediatric survivors of intensive care: a population-based cohort study

Patricia Gilholm, Kristen Gibbons, Sarah Brueningk, Juliane Klatt, Rhema Vaithianathan, Debbie Long, Johnny Millar, Wojtek Tomaszewski, Luregn Schlapbach

Summary: A machine learning model was developed to predict poor school outcomes in children surviving intensive care unit (ICU). By using routine ICU information, the model demonstrated high predictive ability. The results of this study are important for prioritizing follow-up and targeting rehabilitative measures.

INTENSIVE CARE MEDICINE (2023)

Add to Collection

Article Multidisciplinary Sciences

Adeno-associated virus 2 infection in children with non-A-E hepatitis

Antonia Ho, Richard Orton, Rachel Tayler, Patawee Asamaphan, Vanessa Herder, Chris Davis, Lily Tong, Katherine Smollett, Maria Manali, Jay Allan, Konrad Rawlik, Sarah E. McDonald, Elen Vink, Louisa Pollock, Louise Gannon, Clair Evans, Jim McMenamin, Kirsty Roy, Kimberly Marsh, Titus Divala, Matthew T. G. Holden, Michael Lockhart, David Yirrell, Sandra Currie, Maureen O'Leary, David Henderson, Samantha J. Shepherd, Celia Jackson, Rory Gunson, Alasdair MacLean, Neil McInnes, Amanda Bradley-Stewart, Richard Battle, Jill A. Hollenbach, Paul Henderson, Miranda Odam, Primrose Chikowore, Wilna Oosthuyzen, Meera Chand, Melissa Shea Hamilton, Diego Estrada-Rivadeneyra, Michael Levin, Nikos Avramidis, Erola Pairo-Castineira, Veronique Vitart, Craig Wilkie, Massimo Palmarini, Surajit Ray, David L. Robertson, Ana da Silva Filipe, Brian J. Willett, Judith Breuer, Malcolm G. Semple, David Turner, J. Kenneth Baillie, Emma C. Thomson

Summary: An investigation found a possible association between AAV2 infection and host genetics in a recent outbreak of acute hepatitis in children in Scotland. The study used various methods to detect AAV2 infection in plasma and liver samples, and identified pathological features related to the virus in liver biopsy samples.

NATURE (2023)

Add to Collection

Article Critical Care Medicine

Operationalizing Appropriate Sepsis Definitions in Children Worldwide: Considerations for the Pediatric Sepsis Definition Taskforce

Enitan D. Carrol, Suchitra Ranjit, Kusum D. Menon, Tellen D. Bennett, L. Nelson J. Sanchez-Pinto, Jerry J. C. Zimmerman, Daniela C. R. Souza, Lauren R. G. Sorce, Adrienne G. Randolph, Paul Ishimine, Claudio Flauzino de Oliveira, Rakesh Lodha, Lori Harmon, R. Scott J. Watson, Luregn J. Schlapbach, Niranjan C. Kissoon, Andrew C. Argent

Summary: Pediatric sepsis definitions are outdated and lack global applicability and validity. To address this issue, the Pediatric Sepsis Definition Taskforce aims to develop a conceptual framework and rationale for future definitions that consider critical aspects and context-specific factors. Locally adaptable solutions are needed to provide individualized care based on available resources and the probability of sepsis.

PEDIATRIC CRITICAL CARE MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Swiss Sepsis National Action Plan: A coordinated national action plan to stop sepsis-related preventable deaths and to improve the support of people affected by sepsis in Switzerland

Luregn L. A. Schlapbach, Elisa A. Zimmermann, Sylvain Meylan, Martin M. Stocker, Peter M. M. Suter, Stephan M. Jakob

Summary: Switzerland has not yet taken action to address sepsis, a disease that causes over 10 million deaths worldwide each year. A panel of experts formulated 14 recommendations to improve awareness, prevention, and treatment of sepsis in Switzerland, including raising public awareness, improving healthcare workforce training, establishing standards for rapid detection and treatment, and promoting sepsis research. The report presents a coordinated national action plan to prevent, measure, and reduce the burden, death, and disability caused by sepsis in Switzerland.

FRONTIERS IN MEDICINE (2023)

Add to Collection

Article Rheumatology

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

Samuel Channon-Wells, Ortensia Vito, Andrew J. McArdle, Eleanor G. Seaby, Harsita Patel, Priyen Shah, Ekaterina Pazukhina, Clare Wilson, Claire Broderick, Giselle D'Souza, Ilana Keren, Ruud G. Nijman, Adriana Tremoulet, Daniel Munblit, Rolando Ulloa-Gutierrez, Michael J. Carter, Padmanabhan Ramnarayan, Tisham De, Clive Hoggart, Elizabeth Whittaker, Jethro A. Herberg, Myrsini Kaforou, Aubrey J. Cunnington, Oleg Blyuss, Michael Levin

Summary: This study evaluated immunomodulatory treatments for multisystem inflammatory syndrome in children (MIS-C) and found that glucocorticoids or glucocorticoids plus intravenous immunoglobulin were not significantly different from intravenous immunoglobulin alone in terms of clinical efficacy. Initial treatment with glucocorticoids may be a safe alternative to immunoglobulin or combined therapy.

LANCET RHEUMATOLOGY (2023)

Add to Collection

Article Health Care Sciences & Services

Impact of 1-hour and 3-hour sepsis time bundles on patient outcomes and antimicrobial use: A before and after cohort study

Balasubramanian Venkatesh, Luregn Schlapbach, Donna Mason, Kathryn Wilks, Robert Seaton, Paula Lister, Adam Irwin, Paul Lane, Lyndell Redpath, Kristen Gibbons, Endrias Ergetu, Michael Rice

Summary: Implementing 1-hour and 3-hour sepsis bundles for patients with bacteremia resulted in improved bundle compliance and reduced need for ICU admission, without adversely affecting antimicrobial prescription.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)

Add to Collection

No Data Available

Intrabronchial Administration of Activated Recombinant Factor VII in a Young Child With Diffuse Alveolar Hemorrhage

Journal

Publisher

WILEY-BLACKWELL

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper